Dr. John Joseph is a pharmaceutical consultant specializing in CMC, notably pharmaceutical development, analytical research, QA/QC,compliance, CMC due diligence and regulatory.

Dr. Joseph has over 28 years of pharmaceutical development experience, of which first 23 years he spent in Bristol-Myers Squibb as a development scientist and manager, 3 years in Par Pharmaceutical companies as vice president of Analytical R &D, and last two years as a pharmaceutical consultant.

He has provided consulting services to over thirteen (13) companies in the US, Canada, Europe and South America, which include both brand and generic companies in the areas of analytical research, technology, regulatory, QA/QC, compliance, CMC due diligence, quality/productivity, and restructuring.


Ph.D. Biochemistry – Drexel University, Philadelphia, Pennsylvania

M.S. Biochemistry – Drexel University, Philadelphia, Pennsylvania
  • Par Pharmaceutical Companies
  • -Vice President of Analytical R&D

  • Bristol-Meyers Squibb (BMS)
  • -Liason and CMC Team Leader
    -Licensing Team

  • (BMS) Associate Director (CMC) Operations
  • -Chemistry
    -Manufacturing

  • (BMS) Associate Director Analytical R&D
  • -Early Development
    -Pharmaceutical Analysis
    -Chromatography & Spectroscopy Group
    -Phase I IND Support

  • (BMS) Group Leader: Dosage Form Analysis Group

  • (BMS) Senior Research Investigator (API Analysis Group)